|
Market Cap (4-Jun) $5,403,732 (1,096th) |
Close (30-Jun) $0.026 |
Volume (30-Jun) 3,174,615 |
Shortsold (20-Nov) 421,583 (0.03%) (497th) |
|
52w High $0.005 |
52w Low $0.002 |
P/E 11.92 |
EPS 0 |
BIT released this announcement to the ASX on 4 October 2022, 10:13. The announcement is marked as price sensitive, and is 2 page(s) in length and 181.16kb in size.
You can view all announcements from BIT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BIT was 0.160% short sold according to ASIC data. It was ranked the 392nd most shorted stock on the ASX. It remains ranked 497th as of the latest reported data (20 November 2025).
| Other Recent Announcements from BIT | |
|---|---|
| Second Site Approved for Phase 2 Covid-19 Trial | 12 May 2023, 10:16 |
| Commencement Phase 2 Covid-19 Clinical Trial | 4 May 2023, 9:15 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 27 April 2023, 11:00 |
| Second BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited | 4 October 2022, 10:13 |
| Bit225 Covid-19 Human Study Commenced | 14 September 2022, 9:39 |
| BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited | 23 August 2022, 12:16 |
| Appendix 4G and Corporate Governance Statement | 19 August 2022, 15:57 |
You must be logged in to post a reply.
Biotron 